Early detection of cancer can be the next best thing to prevention. There are several widely known risk factors for prostate cancer that may increase the probability of a man to develop prostate cancer. Age, race and family history are the most common today. According to ASCO Cancer.Net, “Prostate cancer that runs in a family, called familial prostate cancer, occurs about 20% of the time.” Sources say that shared genes, similar lifestyles and environments play a role in developing familial prostate cancer. Hereditary prostate cancer accounts for almost 5% of cases. This type of gene mutation is passed down within family generations. A few characteristics for hereditary prostate cancer could include: (more…)
Many online blogs tell us the traditional 4th anniversary gift is flowers or fruit, but at Provision CARES Proton Therapy, we prefer cake! January 20th marks the 4th anniversary of operation for Provision CARES Proton Therapy Knoxville (PCPTK) providing the most innovative cancer treatment in the world, proton therapy.
Dale Clayton first heard about Provision CARES Proton Therapy through a TV commercial. Not knowing he had cancer, he tucked the words “proton therapy” in the back of his mind, hoping that he would never have to remember them. It was February 2015 when Mr. Clayton learned he had prostate cancer. Dale had always been proactive when it came to his health. He said, “my mom always taught me to be proactive.” He went in for regular checkups, yearly physicals, and was well aware of his PSA and gleason score. At his appointment in 2015, all test scores came back normal, but he insisted on a biopsy, just to be sure. Both the doctor and Clayton were shocked, his biopsy came back positive. Dale was diagnosed with low risk, non-aggressive prostate cancer and decided on active surveillance.
Two and a half years later, things started to change. His PSA remained normal but his biopsy showed the cancer had doubled in size. “It’s a miracle we found it,” said Clayton, “I believe God placed the right doctors, urologists, and friends around me to help me make an informed treatment decision.” He researched prostate cancer and treatment options, from surgery to brachytherapy to protons, and there were two things that were very significant to his treatment decision process:
- Cure Rate
- Quality of Life
Sometimes people just get the genetic short end of the stick, but you’d never know Tammy Coleman was one of those people.
Her upbeat personality and contagious enthusiasm belie two heart attacks, a stroke, congestive heart failure and complications related to high blood pressure. And that was all before she was diagnosed with breast cancer—something that ran in her family.
Genetic testing revealed her as the recipient of a genetic mutation that made it highly probable she would develop ovarian cancer too, so within one day Coleman received a double mastectomy and complete hysterectomy.
She had to do chemo, and doctors recommended radiation as well. Because of her existing health problems, particularly related to her heart condition, specialists recommended proton therapy. The targeted nature of protons allow for the benefit of radiation therapy without the collateral damage to surrounding healthy tissue in heart and lungs. (more…)
That included treatment for prostate cancer.
Raffleld started out with a B.S. in physics and a career in the Air Force where he planned and evaluated instructional systems for the military’s intercontinental ballistic missiles program during the Vietnam War. He became a captain, serving as combat crew commander and wing instructor and discovered he enjoyed “arranging resources to accomplish the mission,” he said. “At the time, I didn’t know what that was called, but in business, that’s operations.”
After his military career ended, Raffield didn’t settle into the field he had chosen but embarked in a new direction, starting out as a territory sales manager for Michelin Tire and ending up management and operations for Truckstops of America and Universal Tire.
“I tended to say, ‘I’m going to do what fits me,” he said. (more…)
As is often the case, the momentous often happen as a result of the seemingly insignificant.
Such as Patricia Borchardt’s visit to Buddy Gregg RVs and Motor Homes shortly after a routine screening indicated she might have breast cancer. (more…)
For the past three and a half years, patients have been coming to Provision Cares Proton Therapy Center seeking the best treatment and care for the cancer diagnosis. Many of them have shared their stories with us. Today, we celebrate these survivors by checking in with some of the Provision alumni whose stories we have featured in the past. Click the links to find out more about them on our website, protonstories.com (more…)
Three bills aimed at helping patients get better insurance coverage for proton therapy are making the rounds of committees in Nashville this week, and Provision is urging patients and their friends and families to get involved.
For too many, trying to obtain the best treatment has brought them to blows with their insurance companies.
That was the case for Alexa Gash, who at 29 was diagnosed with throat cancer. Her father had recently suffered from the same diagnosis, and on the advice of the family’s physician, the couple began researching proton therapy. Because of Alexa’s age, they wanted to find a treatment that would be most effective but also spare her from unwanted long-term side effects. With conventional radiation, she risked permanent damage to her salivary glands, taste buds and teeth as well as the potential need for a feeding tube during and post-treatment due to a painful condition called mucositis caused by the excess radiation dose delivered outside of the tumor.
But, although Gash was determined a good candidate for proton therapy, her insurance company, BlueCross BlueShield of Tennessee, disagreed and denied her request for coverage. The company designated her treatment “experimental” and denied appeals to reconsider her case based on the potential ramifications of conventional radiation therapy.
Even though Medicare has covered proton therapy for more than 20 years and the National Comprehensive Cancer Network guidelines support proton therapy in the treatment of head and neck cancer, BlueCross simply said “No.”
In recognition of the gap in coverage and the beneficial impact that proton therapy can have for cancer patients, several legislators have introduced several bills in the Tennessee General Assembly that would require insurance companies to cover proton therapy under specified conditions at no additional cost to the insurance companies. They include:
• House Bill 0883 (Rep. John Holsclaw) & Senate Bill 0210 (Sen. Dr. Mark Green): Requires the state group health insurance program to cover hypofractionated proton therapy for treating cancer under certain conditions.
• House Bill 0523 (Rep. Bob Ramsey) & Senate Bill 0367 (Sen. Doug Overbey): Requires health insurance coverage to cover hypofractionated proton therapy in the same manner as it covers intensity modulated radiation therapy under certain conditions.
• House Bill 0899 (Rep. Mark Pody) & Senate Bill 0758 (Sen. Mae Beavers): Prohibits certain health benefit plans that provide coverage for cancer therapy from holding proton radiation therapy to a higher standard of clinical evidence for medical policy benefit coverage decisions than the health plan requires for coverage of any other radiation therapy treatment.
Currently, the insurance company lobby is fighting the legislation in spite of this increased support for proton therapy in both research and legislative circles, as well as the growing development of proton therapy centers around the world. Instead, they wear out their own insureds with an endless appeal process forcing frustrated patients, their families and healthcare providers to seek redress in the courts or the legislature.
Over the coming days and weeks, the bills will be heard in the Joint Pensions and Insurance Committee chaired by Chattanooga’s Sen. Bo Watson, the Senate Finance and Labor Committee chaired by Franklin’s Sen. Jack Johnson and the House Insurance and Banking Subcommittee chaired by Rep. Kelly Keisling from Pickett County, Tennessee. Sen. Johnson has previously spoken out in favor of proton therapy in publicly supporting the development of Tennessee’s third proton center in his district.
Find out more about how to contact your legislator and help promote these proton therapy bills.
From carney kid to cancer survivor, life hasn’t followed a predictable trajectory for Jim McBride. Nonetheless, this businessman turned pastor and movie producer sees divine purpose in every step.
McBride, a pastor and producer of several popular Christian movies including Fireproof and Facing the Giants, recently completed treatment for prostate cancer at Provision Center for Proton Therapy.
This is an edited version of a message Provision Center for Proton Therapy President Tom Welch sent to our patient Ambassadors, those who have come to Provision for treatment and help to spread the word about proton therapy, in recognition of World Cancer Day.
Today is World Cancer Day. People across the world will be remembering loved ones, supporting friends and family who have been diagnosed with cancer, and celebrating those who are now cancer free. At Provision Proton Therapy Center, we recognize the significance of this day and wanted to share in the celebration. (more…)